This trial is completed!
Search for a recruiting clinical trial for your condition
Your journey
1What's a trial
4Get in touch
More info
You can access this
clinical trial
if you have
Diabetic Foot Ulcers
and you are
over 18
years old
The primary goal of this phase is to monitor the long-term effects.
The treatment is already on the market.
Show me locations

The purpose

The aim of the current study is to support the performance and safety of Woulgan® in the treatment of diabetic foot ulcer in comparison with the commercially available hydrogel Intrasite. Healing and untoward medical events to be evaluated.

Provided treatments

  • Device: Woulgan Gel
  • Device: Intrasite Hydrogel

Locations near you

Unfortunately, there are no recruiting locations near you. Please check the list with all locations below.
Tris trial is registered with FDA with number: NCT02631512. The sponsor of the trial is Biotec Pharmacon ASA and it is looking for 62 volunteers for the current phase.
Official trial title:
Evaluation of Woulgan in Diabetic Foot Ulcer Compared With a Commercial Hydrogel